Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

The objective. Analysis of the course of the postoperative period and number of complications in patients with ovarian cancer during cytoreductive operations with hyperthermic intraoperative intra-abdominal chemotherapy.Subjects and Methods. We assessed the number of bed-days, the volume of infusion...

Full description

Saved in:
Bibliographic Details
Main Authors: D. D. Morikov, V. I. Gorbachev, A. G. Pavlov, V. V. Dvornichenko, A. V. Shelekhov, N. D. Morikov, S. I. Radostev
Format: Article
Language:Russian
Published: New Terra Publishing House 2022-05-01
Series:Вестник анестезиологии и реаниматологии
Subjects:
Online Access:https://www.vair-journal.com/jour/article/view/647
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850028580090675200
author D. D. Morikov
V. I. Gorbachev
A. G. Pavlov
V. V. Dvornichenko
A. V. Shelekhov
N. D. Morikov
S. I. Radostev
author_facet D. D. Morikov
V. I. Gorbachev
A. G. Pavlov
V. V. Dvornichenko
A. V. Shelekhov
N. D. Morikov
S. I. Radostev
author_sort D. D. Morikov
collection DOAJ
description The objective. Analysis of the course of the postoperative period and number of complications in patients with ovarian cancer during cytoreductive operations with hyperthermic intraoperative intra-abdominal chemotherapy.Subjects and Methods. We assessed the number of bed-days, the volume of infusion-transfusion therapy, diuresis, the volume of enteral feeding, the level of leukocytes, urea, creatinine, and lipocalin associated with gel in 45 patients with ovarian cancer after cytoreductive surgery with hyperthermic intraoperative intra-abdominal chemotherapy.Results. All patients developed polyuria while reference parameters of urea and creatinine were stable. Due to these changes, additional markers of acute renal damage were searched for. 15.9% of cases developed leukopenia on days 7–10. The number of complications and deaths does not exceed the world level.Conclusion. A multicomponent and versatile approach to the postoperative management of patients allows minimizing the level of complications and deaths. A search for a more sensitive marker of acute kidney injury is needed.
format Article
id doaj-art-b7d09e15f5f04b98be657ee0803ebbae
institution DOAJ
issn 2078-5658
2541-8653
language Russian
publishDate 2022-05-01
publisher New Terra Publishing House
record_format Article
series Вестник анестезиологии и реаниматологии
spelling doaj-art-b7d09e15f5f04b98be657ee0803ebbae2025-08-20T02:59:46ZrusNew Terra Publishing HouseВестник анестезиологии и реаниматологии2078-56582541-86532022-05-01192404710.21292/2078-5658-2022-19-2-40-47508Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)D. D. Morikov0V. I. Gorbachev1A. G. Pavlov2V. V. Dvornichenko3A. V. Shelekhov4N. D. Morikov5S. I. Radostev6Russian Medical Academy of Continuous Professional Education; Regional Oncology Dispensary; Irkutsk State Medical UniversityRussian Medical Academy of Continuous Professional EducationRegional Oncology DispensaryRegional Oncology Dispensary; Irkutsk State Medical UniversityRussian Medical Academy of Continuous Professional Education; Irkutsk State Medical UniversityS. M. Kirov Military Medical AcademyRegional Oncology Dispensary; Irkutsk State Medical UniversityThe objective. Analysis of the course of the postoperative period and number of complications in patients with ovarian cancer during cytoreductive operations with hyperthermic intraoperative intra-abdominal chemotherapy.Subjects and Methods. We assessed the number of bed-days, the volume of infusion-transfusion therapy, diuresis, the volume of enteral feeding, the level of leukocytes, urea, creatinine, and lipocalin associated with gel in 45 patients with ovarian cancer after cytoreductive surgery with hyperthermic intraoperative intra-abdominal chemotherapy.Results. All patients developed polyuria while reference parameters of urea and creatinine were stable. Due to these changes, additional markers of acute renal damage were searched for. 15.9% of cases developed leukopenia on days 7–10. The number of complications and deaths does not exceed the world level.Conclusion. A multicomponent and versatile approach to the postoperative management of patients allows minimizing the level of complications and deaths. A search for a more sensitive marker of acute kidney injury is needed.https://www.vair-journal.com/jour/article/view/647ovarian canceracute kidney injuryleukopeniacytoreductive surgery (crs)hyperthermic intraperitoneal chemotherapy (hipec)postoperative period
spellingShingle D. D. Morikov
V. I. Gorbachev
A. G. Pavlov
V. V. Dvornichenko
A. V. Shelekhov
N. D. Morikov
S. I. Radostev
Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Вестник анестезиологии и реаниматологии
ovarian cancer
acute kidney injury
leukopenia
cytoreductive surgery (crs)
hyperthermic intraperitoneal chemotherapy (hipec)
postoperative period
title Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
title_full Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
title_fullStr Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
title_full_unstemmed Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
title_short Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
title_sort some aspects of postoperative management of patients with ovarian cancer after cytoreductive surgery using hyperthermic intraperitoneal chemotherapy hipec
topic ovarian cancer
acute kidney injury
leukopenia
cytoreductive surgery (crs)
hyperthermic intraperitoneal chemotherapy (hipec)
postoperative period
url https://www.vair-journal.com/jour/article/view/647
work_keys_str_mv AT ddmorikov someaspectsofpostoperativemanagementofpatientswithovariancanceraftercytoreductivesurgeryusinghyperthermicintraperitonealchemotherapyhipec
AT vigorbachev someaspectsofpostoperativemanagementofpatientswithovariancanceraftercytoreductivesurgeryusinghyperthermicintraperitonealchemotherapyhipec
AT agpavlov someaspectsofpostoperativemanagementofpatientswithovariancanceraftercytoreductivesurgeryusinghyperthermicintraperitonealchemotherapyhipec
AT vvdvornichenko someaspectsofpostoperativemanagementofpatientswithovariancanceraftercytoreductivesurgeryusinghyperthermicintraperitonealchemotherapyhipec
AT avshelekhov someaspectsofpostoperativemanagementofpatientswithovariancanceraftercytoreductivesurgeryusinghyperthermicintraperitonealchemotherapyhipec
AT ndmorikov someaspectsofpostoperativemanagementofpatientswithovariancanceraftercytoreductivesurgeryusinghyperthermicintraperitonealchemotherapyhipec
AT siradostev someaspectsofpostoperativemanagementofpatientswithovariancanceraftercytoreductivesurgeryusinghyperthermicintraperitonealchemotherapyhipec